BMRN BioMarin Pharmaceutical
BioMarin Pharmaceutical earnings company data as of 11:58 AM ET 10/23
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 26 Oct | EPS | 1.16 | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by BMRN's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $4.3M sold by 3 insiders outside a trading plan
- None no planned (10b5-1) sales
-
George Eric Davis EVP, Chief Legal OfficerSale$1.2M 17,557 shares at $66.28 22% of stakeTraded Sep 2 Filed Sep 3
-
Gregory R Friberg EVP, Chief R&D OfficerSale$177K 3,281 shares at $53.85 6% of stakeTraded May 7 Filed May 11
-
Charles Greg Guyer EVP, Chief Technical OfficerSale$997K 16,486 shares at $60.46 17% of stakeTraded Mar 11 Filed Mar 12
-
Gregory R Friberg EVP, Chief R&D OfficerSale$382K 6,326 shares at $60.38 14% of stakeTraded Feb 26 Filed Feb 26
-
George Eric Davis EVP, Chief Legal OfficerSale$1.6M 26,061 shares at $61.36 27% of stakeTraded Feb 26 Filed Feb 26
Also filed in the last 12 months, not counted as buying or selling: 27 stock grants and 13 share withholdings for taxes.
SEC filings
Recent issuer filings from EDGAR, 19 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 8-K | 2.02 | Filing Doc | |
| 8-K | 1.01 | Filing Doc | |
| 8-K | 8.01 | Filing Doc | |
| 8-K | 5.02 | Filing Doc | |
| 8-K | 8.01 | Filing Doc | |
| 8-K | 1.01,7.01,9.01 | Filing Doc | |
| 8-K | 1.01,7.01,9.01 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K/A | 8.01,9.01 | Filing Doc | |
| 8-K | 5.02,5.07 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 1.01,2.01,2.03,7.01,9.01 | Filing Doc | |
| 8-K | 8.01 | Filing Doc | |
| DEF 14A | Filing Doc | ||
| DEFA14A | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.